Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

As Drug Value Frameworks Gain Traction, Patients Seek More Input

Executive Summary

'Patients are ready and willing to have conversations' about trade-offs, National Health Council's Perfetto says.


Related Content

Patients’ View Of Drug Value Is Focus Of Avalere/FasterCures Framework
Drug Pricing: With "Value" Debate In Full Swing, ICER’s Influence Grows
ICER Eyes QALY Ratios, Budget Impacts In Methods Review
Oncology Drug Value Tools From NCCN, ASCO To Get Real-World Testing
Scoring Value: New Tools Challenge Pharma's US Pricing Bonanza
‘DrugAbacus’ Pricing Tool Helps Payers Calculate Fair Value Of Cancer Drugs